Your SlideShare is downloading. ×
  • Like
CONTRACEPTION
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Now you can save presentations on your phone or tablet

Available for both IPhone and Android

Text the download link to your phone

Standard text messaging rates apply

CONTRACEPTION

  • 5,103 views
Published

NEWER CONCEPT ON CONTRACEPTION. A JOINT PROJECT OF IMA AND UNFPA

NEWER CONCEPT ON CONTRACEPTION. A JOINT PROJECT OF IMA AND UNFPA

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
No Downloads

Views

Total Views
5,103
On SlideShare
0
From Embeds
0
Number of Embeds
4

Actions

Shares
Downloads
344
Comments
0
Likes
4

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide
  • The female condom has been available in Europe since 1992 and in 1993 the US FDA approved the female condom for marketing and distribution. The female condom is a strong, soft transparent polyurethane sheath inserted in the vagina before sexual intercourse, providing protection against both pregnancy and STIs. It is stronger than latex, odourless, causes no allergic reactions and unlike latex can be used with both oil based and water based lubricants. There are no serious side effects associated with the female condom and less than 10 percent of users report mild irritations. Laboratory studies indicate that the female condom is impermeable to STIs and HIV
  • These are some of the most important method-specific , i.e., intrinsic characteristics of the IUD, that make it an important method to be available for programs and service providers, and that make it a good potential choice for many women. Our challenge, of course, as change agents working for change agencies is to translate and transmit these method-specific facts and characteristics—and the important recent findings about their even greater safety than had previously been thought—into accurate perceptions and appropriate contraceptive behaviors in the programs and countries we assist. _______ First bullet: efficacy approaches FS, cheaper, easier to provide and reverse: In effect: “Reversible sterilization”—but in quotes because this is not ever how we’d promote it because of inevitable misconceptions and problems that would cause—but it certainly is “food for programmatic thought”
  • In the first year after the procedure: 0.5 pregnancies per 100 women. Within 10 years of the procedure: 1.8 pregnancies per 100 women Effectiveness depends partly on how the tubes are blocked, but all pregnancy rates are very low. Postpatum tubal ligation In the first year after the procedure—0.05 pregnancies per 100 women. Within 10 years after the procedure—0.75 pregnancies per 100 women.
  • Most women can have sterilization With proper counseling and informed consent, sterilization can be used in any circumstances by women who: Just gave birth (within 7 days) Are breastfeeding
  • Fixed uterus due to previous surgery or infection Endometriosis Hernia (umbilical or abdominal wall) Postpartum uterine rupture or perforation or postabortion uterine perforation

Transcript

  • 1. Family planning :Current Contraceptive Scenario in India IMA DISTRICT LEVEL WORKSHOP ON CONTRACEPTIVE UPDATES & SAFE ABORTION TECHNIQUES
  • 2. Contraceptive Updates Seminar, October 2005 Source: NFHS-3 (2005-06) Percentage use of contraception by married Women (15-49) – Total urban rural N
  • 3. Knowledge among eligible population (%) Contraceptive method Ever use (%) Current use (%) Contraceptive Scenario in India Any method 99 55.1 48.2 For all modern methods 98.9 49.3 42.8 Combined Oral pills 79.5 8.4 2.1 IUDs 70.6 5.6 1.6 Condoms 71 7.9 3.1 Female sterilization 98.2 34.2 34.2 Male Sterilization 89.3 2 1.9 Natural methods 48.9 11.8 5
  • 4. Total Fertility Rate
    • The total fertility rate (TFR, sometimes also called the fertility rate, period total fertility rate (PTFR) or total period fertility rate (TPFR)) of a population is the average number of children that would be born to a woman over her lifetime if (1) she were to experience the exact current age-specific fertility rates (ASFRs) through her lifetime, and (2) she were to survive from birth through the end of her reproductive life. It is obtained by summing the single-year age-specific rates at a given time.
    Contraceptive Updates Seminar, October 2005
  • 5. Trends in Contraceptive Use by Method Percent of currently married women age 15-49
  • 6. Unmet need for FP
    • Currently married women not using contraception but who
    • Do not want any more children or
    • Want to wait for two or more years before having another child
    • are defined as having an unmet need for family planning
  • 7. Not using contraception Pregnant or amenorrhoeic Not pregnant or amenorrhoeic Pregnancy intended Pregnancy mistimed Need for spacing Need for limiting Fecund In fecund Want later Want no more Want soon Need for spacing Need for limiting Total Unmet Need Pregnancy unwanted
  • 8.
    • Knowledge gaps; fear of side effects
    Limited access to, and availability of, services Poor quality of services Barriers in meeting contraceptive needs
  • 9. Knowledge Gaps
    • Counselling:
    • Key element for ensuring informed choice, correct and consistent use and continuation of method;
    • Understanding relative effectiveness of the method;
    • Correct use of the method; how it works;
    • Common side-effects; health risks and benefits of the method; signs and symptoms that would necessitate a return to the clinic;
    • Information on return to fertility after discontinuing method use; and information on STI protection .
    Contraceptive Updates Seminar December 2004
  • 10. Access and Quality of Services
    • Skilled providers are key to increase access for contraceptives
    • Providers Skilled in
      • Clinical procedures as per the guidelines
      • Counseling- General and method specific
      • Follow up actions
      • Management of side effects
    • Ctd……..
    Contraceptive Updates Seminar December 2004
  • 11. Access and Quality of Services
    • Physical infrastructure and supplies
    • Site readiness as per prescribed norms
    • Equipments
    • Consistent and quality supplies
    • Availability of educational materials for prospective and current users
    Contraceptive Updates Seminar December 2004
  • 12. Clients with special needs
    • Adolescents
    • Are eligible to use any method of contraception and must have access to a variety of contraceptive choices
    • Many of the same issues regarding appropriate contraceptive use that apply to older clients apply to young people
    • Social and behavioral issues important considerations in the choice and use of contraceptives.
    • Expanding the method choices can lead to improved satisfaction, increased acceptance and increased prevalence of contraceptive use.
    • Proper education and counseling both before and at the time of method selection
    Contraceptive Updates Seminar December 2004
  • 13. Clients with special needs
    • Additional consideration for individuals with a physical disability, mental disability or with serious psychiatric disease
    • The reproductive rights of the individual must be considered in any such decisions
    • Clients with mental disabilities may have difficulty remembering to take pills daily. Clients with physical disabilities may have difficulty obtaining supplies or otherwise accessing the family planning services
    Contraceptive Updates Seminar December 2004
  • 14. Need for Spacing Methods
    • WE NEED SPACING METHODS FOR SAVING LIVES AS WELL AS POPULATION STABILIZATION FOR A QUALITY LIFE.
    • Birth interval is strongly associated with child mortality.
    • A child born <1- ½ year after the previous sibling will have 3 TIMES THE CHANCE OF DYING than after a 3 years spacing interval
  • 15. Spacing Methods for Contraception
    • Barrier Contraceptives:
    • Male Condoms
    • Female Condoms
    • Natural Contraceptives:
    • LAM
    • SDM
    • Oral Contraceptives
    • Injectable Contraceptives
    • Intra Uterine Contraceptive Devices (IUCDs)
  • 16.
    • Male condom
    • Barrier Contraceptive
    • Condom is a sheath made of latex rubber to fit over a man’s erect penis.
    • Condoms are available in different sizes, shapes, colors and textures. Some condoms are coated with a lubricant or with spermicide
    Barrier Contraceptive
  • 17.
    • Condoms help in preventing pregnancy as well as spread of sexually transmitted infections
    • If used correctly, they prevent sperms and ST infections entering the vagina or organisms from vagina entering the penis.
    • With typical use; 14 pregnancies per 100 women in the first year of use.
    • With correct and consistent use every time; 3 pregnancies per 100 women in the first year of use.
    How do condoms work?
  • 18.
    • Prevent pregnancy as well as STIs including HIV.
    • Enables a man to take responsibility of preventing pregnancy and disease.
    • Can be used by men of any age
    • Easily available . Safe, no hormonal side effects.
    • Easy to keep at hand in case of unexpected sex. Can be stopped at any time.
    • Can be used without seeing a healthcare provider first.
    • Often help to prevent premature ejaculation (help man last longer during sex).
    Advantages
  • 19.
    • Latex condoms may cause itching for a few people who are allergic to latex.
    • Also, some people may be allergic to lubricant on some brands of condoms.
    • May decrease sensation, making sex less enjoyable for either partner.
    • Couple must take the time to put the condom on the erect penis before sex.
    • Supply must be ready even if the man or woman is not expecting to have sex.
    • Small possibility that condom might slip off or break during sexual intercourse.
    • If not properly stored, the condoms can go weak and break or if used with oil-based lubricants.
    Disadvantages
  • 20.
    • Only one condition prevents use of condoms—severe allergy to latex rubber (severe redness, itching, swelling after condom use).
    • If the client is at risk of STIs or HIV, she/he should continue to use condoms during sexual intercourse despite the allergy.
    • In general, anyone can use condom safely and effectively if not allergic to latex.
    Medical Eligibility
  • 21.
    • Do not use a condom more than once.
    • Put the condom on erect penis before penis touches the vagina:
      • Hold the pack at its edge and open by tearing from a ribbed edge.
      • Hold the condom so that the rolled rim is facing up, away from penis.
      • Place the condom on the tip of penis.
      • Unroll the condom all the way to the base of the penis. The condom should unroll easily. If it does not, it is probably backwards. If more condoms are available, throw this one away and use a new condom .
    Give specific instructions
  • 22.
    • Most of the condoms are already lubricated; hence there is no need to apply any additional lubricant. This may damage the condom.
    • Now they can have sexual intercourse. After the sexual intercourse (ejaculation), hold the rim of the condom to the base of the penis so it will not slip. The man should pull his penis out of the vagina before completely loosing his erection.
    • Move away from vagina and take off the condom without soiling semen on the vaginal opening.
    • Tie a knot at the rim of the condom. Dispose it off by burying or burning it. Do not leave it where children will find it. Do not use a condom more than once.
    Give specific instructions contd..
  • 23.
    • Immediately insert a spermicidal into the vagina, if spermicidal is not available. If not, washing both, penis and vagina with soap and water should reduce the risk of STIs and pregnancy.
    • Some clients may want to use emergency oral contraception to prevent pregnancy.
    If the condom breaks
  • 24.
    • Urge clients to return to a health care provider, if they or their sex partners :
    • Have symptoms of STIs such as sores on the genitals, pain when urinating or a discharge.
    • Have an allergic reaction to condoms (itching, rash, irritation).
    Specific reason to see a health care provider
  • 25.
    • The Female Condom (FC) is a viable option for women to protect themselves from pregnancy and STIs including HIV.
    • FC is a thin, soft, loose-fitting polyurethane plastic pouch like device that lines the vagina.
    • It has two flexible rings, an inner ring at the closed end, used to insert the device inside the vagina and hold it in place, and an outer ring which remains outside the vagina and covers the external genitalia.
    • The device being made of polyurethane can be used with any type of lubricant without compromising its integrity. This is advantageous in countries where water-based lubricants are hard to find.
    FEMALE CONDOM
  • 26. Product Characteristics
    • Polyurethane sheet measuring 17x7.8 cm
    • Forms strong soft transparent sheath that lines the vagina to create a barrier against sperm and sexually transmitted infections
    • Small ring at closed end is used for insertion and to help maintain the device at the upper end of the vagina
    • Non biodegradable disposal device
  • 27. Female Condom in Place Inner ring Outer ring Plastic sheath with ring at both ends How to grasp female condom for insertion
  • 28. Key lessons learnt
    • FC is not just a product, it needs to be an overall programme
    • Integration into existing strategies and approaches
    • Interaction between user and outreach worker and service provider critical for acceptance
    • Interpersonal communication backed up with regular demonstration
    • Leadership affects acceptability
    • Not an issue of demand or use; but cost and access
  • 29. Effectiveness in pregnancy and disease prevention
    • Contraceptive effectiveness and disease prevention rates seem comparable to those for male condoms
    • 6 months failure rate 0.8% in Japan to 9.5% in Three Latin American sites
    • Estimated annual accidental pregnancy rates for consistent and correct use
    • Female condom 5%; Male Latex condom 3%; Diaphragm 6%; Spermicides 6%
    • WHO Study to compare efficacy is under way
    • Polyurethane is impermeable to small viruses e.g.., CMV, Herpes, Hepatitis B and HIV
  • 30. Acceptability
    • The female condom has been found to have acceptability among both men and women. Studies in numerous countries and in many different settings show that on an average 50-70 % of male and female participants found the female condom to be acceptable.
      • Source: The Female Condom. A Guide for Planning and Programming.
      • WHO and UNAIDS. 2000
  • 31. Safety
    • Female condom is both strong and durable. No special storage arrangements have to be made because the polyurethane is not affected by changes in temperature and humidity.
    • Research confirms that the female condom does not have any serious side effects. It does not alter the vaginal flora or cause significant skin irritation, allergic reaction or vaginal trauma.
    • Source: The Female Condom. A Guide for Planning and Programming. WHO and UNAIDS. 2000
  • 32. Advantages
    • Female-controlled
    • No medical condition appear to limit use.
    • More comfortable to men, less decrease in sensation than male latex condoms. As a result, sensitivity of male partner may not be substantially reduced. It also offers ease of use by men with erectile dysfunction.
  • 33. Advantages Contd…
    • Offer greater protection as it covers both internal and external genitalia.
    • Stronger (polyurethane is 40% more stronger than latex) therefore less frequent breakage (1% compared to 4% for male condoms)
    • Longer shelf-life even under unfavorable storage conditions.
    • CSWs found that female condom allowed them to continue their job without interruption during menstruation (study fro Guatemala and Mexico
  • 34. Disadvantages
    • Not aesthetically pleasing. The coverage of the female external genitalia had a decidedly negative impact on the device’s aesthetics and acceptance.
    • Some women experience difficulties in insertion and removal
    • Expensive than male condoms.
  • 35. How to use ?
    • Some time before the sex, the woman places the closed end of the female condom high in her vagina.
    • The closed end contains a flexible, removable ring to help with insertion.
    • A large flexible ring around the open end of the condom stays outside covering external genitalia.
  • 36. Effectiveness
    • Pregnancies per 100 women in the first year of the use- as commonly used 21.
    • If used correctly and consistently-5.
  • 37. Lactational Amenorrhea Method (LAM)
    • LAM is the use of breastfeeding as a spacing method.
    • LAM provides natural protection against pregnancy and encourages using other method at the proper time.
    • Stops ovulation (release of eggs from ovaries) as it changes the rate of release of natural hormones.
    • Effective as commonly used: 2 pregnancies per 100 women in the first 6 months after childbirth.
    • When used correctly and consistently: 0.5 pregnancies per 100 women in the first 6 months after childbirth.
  • 38. Correct and consistent use means:
    • Her baby is less than 6 months (she has given childbirth within last 6 months)
    • After last childbirth her menstrual period has not returned
    • She is fully breastfeeding—day and night, (at least 8-10 times a day, at least once in 4 hours) and at least once in night (night feeding regularly not more than 6 hours apart) and at least 85% of her baby’s feedings should be breastfeed.
  • 39. Advantages of LAM
    • Can be used immediately after childbirth
    • Encourages the best breastfeeding patterns
    • Effectively prevents pregnancy at least 6 months and may be longer if a woman keeps breastfeeding often, day and night.
    • No direct cost .No supplies or procedure required to prevent pregnancy.
    • No hormonal side effects.
    • No need to do anything at the time of sexual inter course
  • 40. Advantages of LAM
    • Counseling on LAM encourages starting a follow on method at the proper time.
    • Breastfeeding practices required by LAM have other health benefits for mother and baby
    • Provides the healthiest food for baby
    • Protects the baby from life-threatening diarrhea.
    • Helps protect the baby from diseases like measles and pneumonia by passing mother’s immunities to baby.
    • Help develop close bondage between mother and baby .
  • 41. Disadvantages
    • Effectiveness after 6 months is not certain
    • Frequent breastfeeding may be inconvenient or difficult for some women, especially working mothers
    • No protection against STIs including HIV
    • If the mother has HIV, there is a small chance that breast milk will pass HIV to the baby.
  • 42. Medical Eligibility
    • Most women CAN use LAM safely and effectively
    • A woman can use LAM after childbirth, if :
    • Her baby is less than 6 months (she has given childbirth within last 6 months)
    • After last childbirth her menstrual period has not returned
    • She is fully breastfeeding—day and night, (at least 8-10 times a day, at least once in 4 hours) and at least once in night (night feeding regularly not more than 6 hours apart) and at least 85% of her baby’s feedings should be breastfeed.
  • 43. Explaining how to use
    • Breastfeed often: An ideal pattern is at least 8-10 times a day including at least once at night.
    • Breastfeed properly: Counsel her on breastfeeding technique and diet
    • Start other foods when baby is 6 months old. Breastfeed before giving other food, if possible.
  • 44. Start another family planning method when:
    • Her menstrual period return (bleeding in the first 56 days, or 8 weeks, after childbirth is not considered menstrual bleeding)
    • OR
    • She stops fully or nearly fully breastfeeding.
    • OR
    • Her baby is 6 months old (about the time when baby starts sitting up)
    • OR
    • She no longer wants to rely on LAM for family planning
  • 45. Standard Day Method Fertility Awareness Based Method
  • 46. Introduction
    • The standard days method (SDM) is a new natural family planning method for women with menstrual cycles ranging between 26 and 32 days.
    • This method involves identifying the fertile days during each menstrual cycle.
  • 47. Introduction
    • Women with menstrual cycles ranging between 26 and 32 days can prevent pregnancy by avoiding unprotected sexual intercourse on days 8 through 19.
    • Most women using the SDM use a device called Cycle Beads—a string of color-coded beads that help women identify the days of their cycles when they can become pregnant and the days when pregnancy is very unlikely.
  • 48. CycleBeads
  • 49. CycleBeads
  • 50. CycleBeads
  • 51. CycleBeads
  • 52. CycleBeads
  • 53. CycleBeads
  • 54. CycleBeads
  • 55. SDM instructions:
    • On the day that your menstrual period starts, hold the Cycle Beads and move the rubber ring onto the first red bead.
    • Each day, move the rubber ring onto the next bead, moving in the direction of the arrow.
    • Avoid sexual intercourse or unprotected sexual intercourse on the days when the rubber ring is on any of the white beads.
  • 56. Return if,:
    • You are not happy with the method.
    • You think you are pregnant.
    • You want information about or want to start using another family planning method.
    • You think there is any chance you may have been exposed to HIV infection or any other sexually transmitted infection (STI)
  • 57. Oral Contraceptives and Emergency Contraceptive Pills Contraceptive Updates Seminar, October 2005
  • 58. Types Contraceptive Updates Seminar, October 2005 Progesterone-Only oral contraceptive pills Combined oral contraceptives
        • Monophasic: Standard dose, low dose and very
        • low dose pills
        • Multiphasic: Biphasic, Triphasic pills
  • 59. Combined Oral Contraceptive pills Contraceptive Updates Seminar, October 2005 Alteration of endometrium to make it unsuitable for implantation even if the ovum is fertilized. Mechanism of action: Changes in cervical mucous which make it hostile for sperms Inhibition of ovulation by suppressing FHS and LH
  • 60. Effectiveness Contraceptive Updates Seminar, October 2005 Failure rate is 0.3% as commonly used and only 0.1% on correct and consistent use. 99.97% to 99.99%.
  • 61. Health Benefits Contraceptive Updates Seminar, October 2005 Fertility related benefits
        • Prevention of pregnancy
        • Offers protection against ectopic pregnancy
    Menstrual benefits Menstrual cycle stabilization Reduced iron deficiency anaemia due to lighter menstrual cycles More regular menstrual cycles Less dysmenorrhea Less severe pre-menstrual symptoms
  • 62. Health Benefits Contraceptive Updates Seminar, October 2005 Protection from some cancers e.g. endometrial and ovarian cancer Protection against benign diseases e.g. benign breast diseases like fibrocystic and fibroadenomatosis disease decreased by 50-70% Other possible health benefits
        • Protection against pelvic inflammatory diseases
        • Reduces risk of follicular cyst by 50% and corpus luteal
        • cyst by 80%.
        • Past contraceptive use protects women after they reach menopause; reduced risk of low bone mineral density was documented
        • Reduction in acne
  • 63. Side effects Contraceptive Updates Seminar, October 2005 Breakthrough bleeding-common with low dose progesterone pills due to low or absent estrogen. Nausea, vomiting, decreased appetite; usually pass off after 2-3 months of use Oligo and ammenorrhoea due to lack of proliferation of endometrium of cycle. Common among women who had menstrual problems before starting oral contraceptive pills.
  • 64. Side effects Contraceptive Updates Seminar, October 2005 Vaginal discharge due to congestion and hypertrophy of cervical epithelium. Breast changes- oedema, heaviness and tenderness. Chloasma Weight gain in some cases due to estrogen and progesterone . Acne and oily skin.
  • 65. ELIGIBILITY CRITERIA: (For low dose combined contraceptive pills) Contraceptive Updates Seminar, October 2005 Most women can use Combined Oral Contraceptives. Are of any age, including adolescents and over 40 (except women 35 years or older and who smoke) Smoke cigarettes but are under age 35 Have just had abortion or miscarriage
  • 66. ELIGIBILITY CRITERIA: (For low dose combined contraceptive pills) Contraceptive Updates Seminar, October 2005 Heavy, painful menstrual periods or iron deficiency anemia (condition may improve) Benign breast disease Diabetes without vascular, kidney, eye or nerve disease Irregular menstrual periods Mild headaches Malaria Varicose veins
  • 67. ELIGIBILITY CRITERIA: (For low dose combined contraceptive pills) Contraceptive Updates Seminar, October 2005 Thyroid disease Endometriosis Pelvic inflammatory disease Begin ovarian tumour Past ectopic pregnancy Uterine fibroids Tuberculosis (unless taking Rifampicin)
  • 68. Who cannot use COCs? Contraceptive Updates Seminar, October 2005 Fully Breastfeeding within 6 month postpartum; If partially BF she can start after six weeks Are age 35+ and smoke more than 15 cigarettes per day Have multiple risk factors for arterial cardiovascular disease Have hypertension with systolic BP 140-159 and diastolic 90-99 and those having vascular disease. Have clear history of deep vein thrombosis (DVT), pulmonary thrombosis or current DVT or pulmonary thrombosis. Have known thrombogenic mutations. Have current history of ischemic heart disease or known hyperlipidaemias
  • 69. Who cannot use COCs? Contraceptive Updates Seminar, October 2005 Women who have Migraine with aura Current breast cancer Diabetes with neuropathy, retinopathy, nephropathy and other vascular disease Acute hepatitis or severe cirrhosis of liver or benign or malignant liver tumours Complicated pulmonary hypertension, risk of atrial fibrillation, history of subacute bacterial endocarditis
  • 70. Important Contraceptive Updates Seminar, October 2005 Women having the above health conditions should be encouraged to use other more appropriate contraceptives than COCs.
  • 71. When can a woman start COCs? Contraceptive Updates Seminar, October 2005 During a menstrual cycle Amenorrhoea Between 2 menstrual cycles Breastfeeding Switching to another hormonal method Switching from non-hormonal method After miscarriage or abortion Switching from IUD (including hormonal)
  • 72. Key steps for providing COCs Contraceptive Updates Seminar, October 2005 Give pills, 3 months supply if possible. Running out of pills is one of the major reasons for unintended pregnancy. Explain how to use If possible give condoms or spermicide to use: Until she can start taking the pills If she starts packet of pills late, misses pills in row or stops taking pills for any other reason If there is possibility of transmission of STIs/HIV Show her how to use condoms and spermicide. Invite the client to come back any time if she has any questions, problems or wants another method Plan for return visit
  • 73. Pills missed? Contraceptive Updates Seminar, October 2005 WHAT TO DO IF YOU MISS ONE OR MORE PILLS Every time you miss one or more active pills (days 1-21): In these special cases, ALSO follow these special rules If you miss nay of the 7 inactive pills (in a 28–pill pack only) 1. Take a pill as soon as you remember 1. Take the next pill at the usual time 3. Keep taking active pills as usual, one each day Source: Johns Hopkins University Bloomberg School of Health, Population information program Started pack 2 or more days late? Missed 2–4 pills of first 7 pills days 1–7 Missed 5 or more active pills in a row days 1–7 Missed 2–4 pills of last 7 active pills days 15–21 Avoid sex or another method for 7 days Finish all active pills in the pack. Do not take last 7 (inactive) pills in 28–pill pack. Do not wait 7 days to start next 21– pill pack. Start a new pack. 1. Throw away missed pills 2. Keep taking one pill each day 3. Start new pack as usual
  • 74. What to do at follow up visit Contraceptive Updates Seminar, October 2005 Ask if client has any questions or anything to discuss. Ask client about her experience with the method. Give her any information she needs and invite her to return any time for help. If she has problems that cannot be resolved, help her choose another method. Plan for next visit before she will need more pills.
  • 75. Emergency Contraceptive Pills (ECPs) Contraceptive Updates Seminar, October 2005 Emergency contraception: Is method of contraception used before missing a period to prevent pregnancy. It is also called “morning after” or post-coital contraception.
  • 76. Indications for using emergency contraception Contraceptive Updates Seminar, October 2005 A woman who had unprotected sex, and wants to prevent pregnancy. For example: She did not expect to have sex and was not using any contraception Sex was forced Condom broke or slipped She ran out of contraceptives, or was irregular in taking pills and did not use condoms or spermicide. She is late for a contraceptive injection.
  • 77. What pills can be used as ECPs? Contraceptive Updates Seminar, October 2005 Progestin-only dedicated products: Levonorgesterol pills are generally used GOI emergency contraceptive pills also available through public systems Several commercial preparations available in market
  • 78. Contraceptive Updates Seminar, October 2005 Levonorgesterol alone EC pills- A dedicated product 0.75 mg of tablets Levonorgestel available in India. The current recommendation: 1 pill of LNG 0.75 mg to be taken as soon as possible after unprotected coitus (within 72 hours) followed by another pill 12 hours later. Depending on the composition 1 pill of 1.5mg in a single dose can be taken.
  • 79. GOI Guidelines Contraceptive Updates Seminar, October 2005 The Government of India guidelines for Emergency Contraception recommend use of Levonorgestrel (progestogen only) LNG as a “dedicated product” for effective emergency contraception. The Drug Controller of India has approved only Levonorgestrel for use as ECP.
  • 80. How effective are ECPs? Contraceptive Updates Seminar, October 2005 Pregnancy rate 8%, if women have sex once in the second or third week of the menstrual cycle without using contraception. Pregnancy rate 2% if women use combined oral contraceptives for emergency contraception Pregnancy rate 1% if women use progestin-only ECPs
  • 81. How do ECPs work? Contraceptive Updates Seminar, October 2005 Probable mechanisms are: Inhibition or delay of ovulation Thickening of cervical mucous Direct inhibition of fertilization Histological and biochemical alteration in endometrium leading to impaired endometrial receptivity to implantation of the fertilized egg Alteration in transport of egg, sperm and embryo Interference with corpus luteum function and luteolysis
  • 82. Medical eligibility criteria for Emergency Oral Contraception Contraceptive Updates Seminar, October 2005 Any woman can use emergency oral contraception if she is not already pregnant within the stipulated time period.
  • 83. When should ECPs be taken Contraceptive Updates Seminar, October 2005
    • ECPs should be taken as soon as possible after unprotected intercourse. The first dose should be taken within 72 hours after intercourse
    Question carefully to determine likelihood of pregnancy. If women is pregnant, do not provide Emergency Oral Contraceptives. Provide pills for Emergency Oral Contraception
  • 84. Advice on common problems Contraceptive Updates Seminar, October 2005 Nausea: Eat something soon after taking the pills to reduce nausea.Take anti-emetic half an hour before taking emergency contraceptive pills and every 4-6 hours thereafter. Vomiting: If the woman vomits within 2 hours of taking the pills, she may take another dose. Otherwise she should not take any extra pills. Extra pills will not make the method more effective, and they may increase nausea. Her next monthly period may start a few days earlier or later than expected. Reassure her that this is not a bad sign.
  • 85. Specific reasons to return to the healthcare provider Contraceptive Updates Seminar, October 2005 Advise her to return or see another health care provider if her next period is quite different from usual for her, especially if: There is unusually light bleeding (possibly pregnancy) Bleeding does not start within 4 weeks (Possible pregnancy) Unusually painful (possibly ectopic pregnancy). But emergency oral contraception does not cause ectopic pregnancy. If there are symptoms of sexually transmitted diseases.
  • 86. Some facts about ECPs Contraceptive Updates Seminar, October 2005 Will not disrupt an established pregnancy Offer no protection against STIs. Do not provide continuing protection from pregnancy. No medical conditions rule out ECPs.
  • 87. Providing ECPs: Key steps Contraceptive Updates Seminar, October 2005 Help the client feel at ease. Ask when unprotected sex took place. Give the woman pills. Explain how to take them. She can take first dose at once.
  • 88. Providing ECPs: Key steps Contraceptive Updates Seminar, October 2005 Explain and discuss important points about ECPs. Discuss her ongoing need for contraception Tell her that if she vomits within 2 hours of taking pills, she may take another dose.
  • 89.  
  • 90.  
  • 91.  
  • 92.  
  • 93.  
  • 94.  
  • 95.  
  • 96.  
  • 97.  
  • 98.  
  • 99.  
  • 100.  
  • 101.  
  • 102.  
  • 103.  
  • 104.  
  • 105.  
  • 106.  
  • 107.  
  • 108.  
  • 109.  
  • 110.  
  • 111.  
  • 112.  
  • 113.  
  • 114.  
  • 115.  
  • 116.  
  • 117.  
  • 118.  
  • 119.  
  • 120.  
  • 121.  
  • 122.  
  • 123.  
  • 124.  
  • 125.  
  • 126.  
  • 127.  
  • 128.  
  • 129.  
  • 130.  
  • 131.  
  • 132. In India DMPA currently approved and available in 106 countries and NET-EN in over 60 countries. Some social marketing organizations also provide ICs Approved by Drug Controller of India and commercially available.
  • 133. Continuation rates with DMPA at the end of one year 50-80%, but as low as 19% in one Indian study Discontinuation due to Continuation rate …
      • Amennorrhoea: additional 11-12% for DMPA, 7-8% for NET-EN
      • Bleeding abnormalities: 10-15% for both DMPA and NET-EN.
    For monthly injectables, continuation rates range from 66 to 82%. Discontinuation due to
      • Amenorrhoea 2%
      • Bleeding abnormalities 7%
  • 134. IUCD
    • Worldwide IUCD Usage
    • Country Any method IUCD
    • Europe 73% 9%
    • North America 75% 2%
    • China 84% 36%
    • Vietnam 79% 38%
    • Cuba 73% 43%
    • Egypt 60% 38%
    • Jordan 56% 24%
    • Korea 80% 13%
    • India 54% 2%
  • 135. Types of IUCD
    • 1 st Generation : Unmedicated
    • IUCDs
    • 2 nd Generation: Copper-
    • bearing IUDs
    • 3 rd Generation :Hormone
    • releasing IUDs
  • 136. Second generation IUDs
    • Second generation IUDs
    • Examples are :CuT-380A, Cu-T 220C, Nova T and Multiload 375
    • - Are much more effective have less side-
    • effects than unmedicated IUDs
    • - similar in terms of effectiveness, side
    • effects, expulsion, and continuation
    • rates.
    • TCu-380A
  • 137. IUCD 380 A : An Excellent Spacing Method
    • • C omparable to Female sterilisation
    • 10 YRS EFFECTIVENESS
    • “ REVERSIBLE STERILIZATION ”
    • Completely reversible
    • Very safe for most women, including postpartum, post abortion, or interval, breastfeeding, young Nulliparous
    • Cochraine Review
    National F.P. Programme
  • 138. Re-emergence of the IUCD
    • Recent research has led to important changes in WHO eligibility criteria
    • Risk of upper genital infections is negligible
    • Despite many misconceptions, IUCD users have higher satisfaction rates than users of many other methods (99% vs 91% for pill users)
  • 139. Reasons of Non Acceptance of IUCD
    • Lack / Poor Counseling
    • Poor motivation of Client
    • Poor Selection of Cases
    • Poor insertion technique
    • Poor infection prevention strategies
    • Poor post procedural counseling
  • 140. Medical Eligibility Criteria for Contraception – WHO
    • People specific need
    • Specific medical conditions
    • Expressed desire of women or couple
    • Cafeteria approach
    • Helping to make informed
    • choice
    • Reproductive right of woman
    Couple / individual specific Contraceptive Prescription
  • 141. MEC - WHO Category 1
    • Lactation amenorrhea (Pregnancy ruled out)
    • Post menstrual, any time in cycle
    • Postpartum > 6 wks
    • Small uterine fibroid or benign ovarian cyst
    • No medical disease
    • Emergency contraception
    • h/o Ectopic Pregnancy
    Can use IUCD with no Restriction
    • Minimal vaginal discharge
    • History of PID with a subsequent pregnancy
    • Women who have breast disease, including cancer
    • H/o Viral hepatitis, malaria
    • Controlled diabetes, hypertension
    • Women who smoke or obese
  • 142. Medical Eligibility criteria WHO criteria 2
    • < 20 yrs of age
    • 2 nd trimester abortion (spontaneous or induced)
    • < 48 hours of post-partum
    • Uterine anomaly but no uterine cavity distortion
    • No genital infection but at risk for STIs
    • Physiological Vaginal discharge + Past h/o PID
    • HIV sero-positive but healthy, on ART
    • Complicated heart disease
    • Uterine Prolapse 1 o or 2 o or RVF
    Can use CuT but additional care needed
  • 143. Medical Eligibility criteria WHO criteria 3
    • Heavy & prolonged menses
    • Benign Trophoblastic disease
    • At higher risk of STIs
    • AIDS patient not on ART
    • 3 rd degree UT prolapse or VVF
    Use of CuT not recommended
  • 144. Medical Eligibility criteria WHO criteria 4
    • Pregnant women
    • Post abortion or Puerperal sepsis
    • Malignant trophoblastic disease
    • Cervical or uterine cancer
    • Gross uterine anomaly or big fibroids
    • Current PID, Pelvic tuberculosis
    • Unexplained vaginal bleeding
    Should not use IUCD
  • 145. WHO Eligibility Criteria Source : WHO 2004. Category Description When clinical judgment is available When clinical judgment is limited 1 No restriction for use Use the method under any circumstances Use the method 2 Benefits generally outweigh risks Generally use the method 3 Risks generally outweigh benefits Use of method not usually recommended, unless other methods are not available/acceptable Do not use the method 4 Unacceptable health risk Method not to be used
  • 146.
    • Counselling
    • Giving need-based correct and useful information.
    • Facilitating the client to make informed decision.
    • Going beyond the presenting condition and symptoms and identifying the non-visible factors.
  • 147. Counselor must facilitate the client to:
    • Choose and use a method.
    • Solve any problems.
    • Get accurate information.
    Assure the client about privacy and confidentiality.
  • 148. GOOD COUNSELOR
    • G-good technical knowledge
    • O-obtains information
    • O-objectively answers
    • D-demonstrates professionalism
  • 149. REMEMBER! Counseling does not terminate when the client accepts a method or undergoes the procedure, its process completes when the acceptor returns to the service centre/provider for follow up and goes back home with satisfaction.
  • 150. Certain clarification related to medical eligibility
    • Postpartum
    • Evidence suggests that there was increase in expulsion rates with delayed postpartum insertion compared to immediate insertion and with immediate postpartum insertion compared to interval insertion.
    • Post abortion insertion
    • No difference in risk of complications for immediate versus delayed insertion of an IUD after abortion
    • Expulsion was greater when an IUD was inserted following a second-trimester abortion
  • 151.
    • Vulvular heart disease
    • Prophylactic antibiotics to prevent endocarditis
    • PID and continuation of IUD
    • To ensure continuation of IUD in cases of PID,
    • Treatment of PID using appropriate antibiotics
    • No need for removal of the IUD if the client wishes to continue to use.
    • Clinical evidences suggest that among IUD users treated for PID, there was no difference in clinical course if the IUD was removed or left in place
    Certain clarification related to medical eligibility …….
  • 152.
    • STI and IUD
    • No evidence to suggest the increased risk of PID with IUD insertion among women with STI
    • HIV/AIDS
    • • No increased infection risk
    • • IUD use among HIV-infected women was
    • not associated with increased risk of
    • transmission to sexual partner
    Certain clarification related to medical eligibility ……… ..
  • 153. Managing problems
    • Pregnancy
    • Exclude ectopic pregnancy.
    • Explain the risk of second trimester miscarriage, pre-term delivery and infection if the IUD is left in place.
  • 154. What is LNG-20
    • Consists of plain Nova T device with a silastic reservoir attached to the vertical arm
    • The silastic reservoir is impregnated with levonorgestrel and is covered with a rate-limiting silastic membrane.
    • The release rate of levonorgestrel is approximately 20 micrograms/24 hours for at least 5 years.
  • 155. Indications
    • Particularly useful for 2 groups of women:
    • Who have been pregnant and do not want to any more children in next few years
    • Age group of 30-40yrs who have completed their families and want a reliable long term method of contraception
  • 156. Disadvantages
    • Costlier than copper-bearing IUDs
    • Can cause irregular bleeding or spotting in the first six months of use
    • Not suitable for women who are at risk of sexually transmitted infections or ectopic pregnancy.
  • 157. Medical Eligibility
    • Most of the medical eligibility criteria for copper-bearing IUDs and LNG-20 IUDs are similar; however, due to hormonal nature certain precautions should be taken
  • 158. Insertion Technique
    • No-touch technique
    • Loading the IUD in the inserter while both parts are still in the sterile package
    • Cleaning the cervix with antiseptic before IUD insertion;
    • Not to touch the vaginal wall or speculum blades with the uterine sound or loaded IUD inserter
    • Passing both, uterine sound and IUD inserter only once through the cervical canal.
  • 159.
    • In women with endometriosis
    • Use is associated with decreased dysmenorrhoea and pelvic pain
    • Beneficial in treating menorrhagia in women with heavy or prolonged bleeding
    • Among women with fibroids
    • No adverse health events have been reported
    • There was a decrease in symptoms and size of fibroids for some women
    Certain clarification related to medical eligibility
  • 160. Examination of Client and Preparation before Insertion
    • 1. Client Counseling: Explain the procedure to the client. This helps the client relax, making insertion easier and less painful.
    • 2. Infection prevention: Use disinfected instruments, sterile hand gloves and clean the area with Betadine. This minimizes the chances of uterine infection.
    • 3. Speculum examination and bimanual pelvic examination : The speculum examination is done to check for signs of genital tract infection. The bimanual examination determines the size, position, consistency, and mobility of the uterus and identifies any tenderness. A retroverted uterus requires special care during insertion.
    • 4. Sounding of the uterus: Should be done slowly and gently to determine its depth and direction. This reduces the risk of perforating the uterus, which usually occurs because the sound is inserted too deeply or at the wrong angle.
  • 161. Sounding Length
    • For guard adjustment
  • 162. Preparing the IUD for insertion
  • 163. Opening the Pack
    • Partially open the package from the end marked OPEN, approximately halfway to the flange .
  • 164. Loading
    • No Touch Loading requires that the loading be done through the protective pack.
  • 165. Adjusting Guard
    • The Guard is being adjusted in the video you see now …
  • 166. Peeling the Pack
    • After adjusting guard, the pack is finally peeled to take out the assembly .
  • 167. Taking out the IUD
    • Care must be taken not to touch the IUD.
  • 168. Recapitulation of Insertion
    • 1. Swab the cervix with antiseptic.
    • Gently introduce the loaded inserter assembly through the
    • cervical canal until the flange comes in contact with the cervix.
    • 3. Hold the plunger stationary and withdraw the insertion tube slightly so as to release the arms of the T.
    • 4. Gently push the insertion tube upwards, towards the top of the uterus until a slight resistance is felt. This ensures that the T is closer to the fundus.
    • 5. Withdraw the plunger while holding the insertion tube stationary.
    • 6. Gently withdraw the insertion tube.
    • 7. Cut the threads so that they protrude only 2-3 centimeters into vagina. Use sharp scissors.
  • 169. Swab the cervix with antiseptic. Gently introduce the loaded inserter assembly through the cervical canal until the flange comes in contact with the cervix.
  • 170. Hold the plunger stationary and withdraw the insertion tube so as to release the arms of the T.
  • 171. Gently push the insertion tube upwards, towards the top of the uterus until a slight resistance is felt. This ensures that the T is closer to the fundus.
  • 172. Withdraw the plunger while holding the insertion tube stationary.
  • 173. Gently withdraw the insertion tube. Cut the threads so that they protrude only 2-3 centimeters into vagina. Use sharp scissors.
  • 174. Caution
    • The IUD should be loaded in to the inserter tube not more than five minutes before insertion.
  • 175. Family Planning Permanent Methods: Male & Female Sterilisation Dr. Kiran Ambwani, Deputy Commissioner, Family Planning Divison, MoHFW GOI
  • 176. Source: Family Planning: A Global Handbook for Providers, WHO, 2007
  • 177. Types of Female Sterilisation Female Sterilization In: Landry E, ed. Contraceptive Sterilization: Global Issues and Trends. New York: Engender Health; 2002: 139-160 Procedure Timing Technique Minilaparotomy
    • Post Partum
    • Post Abortion
    • Interval
    • Tubal Ligation or Excision
    Laparoscopy
    • Interval Only
    • Mechanical Devices
    • (Clips, Rings)
  • 178. Effectiveness of Female Sterilisation Within 10 years of the procedure: 1.8 pregnancies per 100 women In the first year after the procedure: 0.5 pregnancies per 100 women. Effectiveness depends partly on how the tubes are blocked, but all pregnancy rates are very low Postpartum tubal ligation
      • In the first year after the procedure - 0.05 pregnancies per 100 women.
      • Within 10 years after the procedure - 0.75 pregnancies per 100 women.
    Recanalisation surgery is difficult, expensive and has low success rate
  • 179. Who can avail Female Sterilisation?
      • Safe for all women
      • No requirement for Husband’s Permission
      • After 21 years of age
      • Who have just given birth (Within 7 days)
      • Who are breast feeding
      • Who are HIV Positive
    GOI Standards for female and male sterilisation The client should be screened using Medical Eligibility Criteria as enumerated in the “Standards for Female & Male Sterilisation”
  • 180. Case Selection
    • (Self- declaration by the client will be the basis for this information)
    • Clients should be ever-married.
    • Female clients should be below the age of 49 years and above 22 years.
    • The couple should have at least one child whose age is above one year unless the sterilization is medically indicated.
    • Clients or their spouses must not have undergone sterilization in the past (not applicable in the cases of failure of previous sterilization).
    • Clients must be in a sound state of mind so as to understand the full implications of sterilization.
    • Mentally ill clients must be certified by a psychiatrist and consent should be given by a legal guardian/spouse of sound state of mind.
  • 181. DELAY female sterilization and treat as appropriate or refer in case of
    • Pregnancy
    • Postpartum or second trimester abortion (7-42 days)
    • Serious postpartum or post-abortion complications
    • Unexplained vaginal bleeding
    • Severe pre-eclampsia, eclampsia
    • Pelvic inflammatory disease within past 3 months
    • Current STI
    • Pelvic cancers
    • Malignant trophoblast disease
  • 182. REFER to a centre with experienced staff and equipment in case of Endometriosis Fixed uterus due to previous surgery or infection Hernia (umbilical or abdominal wall) Postpartum uterine rupture or perforation Post-abortion uterine perforation
  • 183. Use CAUTION in case of
    • Current breast cancer
    • Past PID since last pregnancy
    • Uterine fibroid
    • Mild high blood pressure (140/90 – 155/99 mm)
    • History of high blood pressure
    • Past stroke or heart disease
    • Valvular heart disease without complications.
  • 184. Requirements of a safe procedure Client assessment Counseling Laboratory tests Informed consent Anesthesia Infection prevention Instructions to accompanying persons
  • 185. Counseling: Ensure Informed Choice A FRIENDLY COUNSELLOR: LISTENS to the concerns of the women GIVES clear & practical information HELPS her to make informed choice to avoid later regret Source: Family Planning: A Global Handbook for Providers, WHO, 2007
  • 186.
    • Temporary contraceptives also are available to the client.
    • Voluntary sterilization is a surgical procedure.
    • There are certain risks of the procedure as well as benefits. (Both risks and benefits must be explained in a way that the client can understand.)
    • If successful, the procedure will prevent the client from ever having any more children.
    • The procedure is considered permanent and probably cannot be reversed.
    • The client can decide against the procedure at any time before it takes place
    6 Points of Informed Consent Source: Family Planning: A Global Handbook for Providers, WHO, 2007
  • 187. INFORMED CONSENT FORM FOR STERILIZATION OPERATION / RE-STERILIZATION
    • 1. Name of the Client: Shri/Smt……………………………………………………….
    • 2. Husband/Wife’s Name: Shri/Smt …………………………………………………….
    • Address ………………………………………………………………….
    • ……………………………………………………………… ..
    • 3. Father’s Name : Shri…………………………………………………………
    • Address ….……………………………………………………………………..
    • 4. Religion ………………………………………………………………………
    • 5. Educational Qualifications……………………………………………………………
    • 6. Business/Occupation………………………………………………………………..
    • 7. Operating Centre…………………………………………………………………..
    • I Smt/Shri …………………………….hereby give the consent for my sterilization operation. I am married and my husband/wife is alive. My age is …………years and my husband/wife’s age is……years. We have………………..male and……………female living children. The age of my youngest living child is …………years.
    • I am aware that I have the option to decide against the sterilization procedure at any time without sacrificing my rights to other reproductive health services.
    • (a) I have decided to undergo the sterilization / re-sterilization operation on my own without any outside pressure, inducement or force. I declare that I / my spouse has not been sterilized previously (may not be applicable in case of re-sterilization).
    • (b) I am aware that other methods of contraception are available to me.
    • I know that for all practical purposes this operation is permanent and I also know that there are still some chances of failure of the operation for which the operating doctor and health facility will not be held responsible by me or by my relatives or any other person whomsoever
    • (d) I am aware that I am undergoing an operation, which carries an element of risk.
    • (e) I have been explained the eligibility criteria for the operation and I affirm that I am eligible to undergo the operation according to the criteria.
    • I agree to undergo the operation under any type of anesthesia, which the doctor/health facility thinks suitable for me, and to be given other medicines as considered appropriate by the doctor/health facility concerned.
    • If after the sterilization operation, there is any missed menstrual cycle of mine/my
    • spouse, then I/my spouse shall report within two weeks of missed menstrual cycle to
    • the doctor/health facility and may avail the choice to get the MTP done free of cost.
    • In case of complications following sterilization operation including failure, I will accept the compensation as per the existing provisions of the Government of India Family Planning Insurance Scheme as full and final settlement.
    • That if I/my wife gets pregnant after failure of sterilization operation and I will not be able to get the pregnancy aborted within two weeks, then I will not be entitled to claim any compensation over and above the compensation under Family Planning Insurance Scheme from any court of law in this regard or any compensation for upbringing the child.
    • I agree to come for follow-up to the Hospital/Institution/Doctor/health facility as instructed, failing which I shall be responsible for consequences, if any.
    • I understand that Vasectomy dose not result in immediate sterilization. *I agree to come for semen analysis at the end of 3 months or, more to confirm the success of sterilization surgery (Azoospermia) failing which I shall be responsible for consequences, if any.
    • (* Applicable for male sterilization cases)
    • I have read the above information. # The above information has been read out and explained to me in my own language and that this form has the authority of a legal document.
    • Name & Signature/Thumb Impression
    • of the Acceptor
    • …………………………………………
  • 188. INFORMED CONSENT FORM FOR STERILIZATION OPERATION / RE-STERILIZATION
    • Signature of Witness:
    • …………………………………………
    • Full Name………………………………
    • Full Address……………………………..
    • # (Only for those beneficiaries who cannot read and write)
    • Applicable to cases where the client cannot read and the above information is read out.
    • Shri/Smt ………………………………………….. have been fully explained about the contents of the Informed Consent Form in his/her local language.
    • Signature of Counselor**
    • Full Name
    • …………………………………
    • Full Address
    • …………………………………
    • I certify that I have satisfied myself that -
    • 1) Shri/Smt……………………………………is within the eligible age-group and is medically fit for the sterilization operation.
    • 3) I have explained all clauses to the client and that this form has the authority of a legal document.
    • 4) I have filled the Medical record – cum- checklist and followed the standards for sterilization procedures laid down by the Government of India.
    • ………………………………… . ……..…..……………………………………….
    • Signature of Operating Doctor Signature of Medical Officer in-charge of the
    • Facility
    • (Name and address) Seal (Name and address) Seal
    • DENIAL OF STERILIZATION
    • I certify that Shri/Smt……………………………………is not a suitable client for re-sterilization/sterilization for the following reasons:
    • 1.
    • 2.
    • He/She has been advised the following alternative methods of contraception.
    • Signature of the Counselor** or
    • Doctor making the decision
    • (Name and full Address)
  • 189. Five common causes of female sterilization failure Surgical “occlusion” of a structure other than the fallopian tube (most often, the round ligament) An undetected luteal-phase pregnancy that was present at the time of sterilization Incomplete or inadequate occlusion of the fallopian tube Misplacement of the mechanical device Development of tuboperitonoal fistula.
  • 190. Male Sterilisation OR Vasectomy A safe & Effective Method of Contraception
  • 191. Source: Family Planning: A Global Handbook for Providers, WHO, 2007
  • 192. Methods of Male Sterilisation
    • Conventional Vasectomy
    • No-Scalpel Vasectomy (NSV)
      • Only three instruments used
      • No incision and stitch
      • Less pain and Bruising & Quick Recovery
      • Fewer infections and hematoma
      • No residual pain – perivasal anaesthesia
  • 193. Case Selection
    • (Self- declaration by the client will be the basis for this information)
    • Clients should be ever-married.
    • Male clients should ideally be below the age of 60 years
    • The couple should have at least one child whose age is above one year unless the sterilization is medically indicated.
    • Clients or their spouses must not have undergone sterilization in the past (not applicable in the cases of failure of previous sterilization).
    • Clients must be in a sound state of mind so as to understand the full implications of sterilization.
    • Mentally ill clients must be certified by a psychiatrist and consent should be given by a legal guardian/spouse.
  • 194. Medical Eligibility Most men who want vasectomy can have safe and effective procedures in routine settings. Most men can have vasectomy This includes men of any age who are HIV positive or at high risk of HIV or other STIs have sickle cell disease or hereditary anaemia; have no children
  • 195. Medical Eligibility Active sexually transmitted infection If he has the following, DELAY vasectomy and refer for treatment Scrotal skin infection or mass in the scrotum Acute systemic infection or significant gastroenteritis Inflamed (swollen and tender) tip of penis, ducts or testicles
  • 196. If he has any of the following, REFER him to a center with experienced staff and equipment that can handle potential problems: Hernia in the groin (can perform vasectomy at the same time as repairing hernia. If this is not possible, the hernia should be repaired first) Filariasis or elephantitis Undescended testicles - both sides Current-AIDS related illness Coagulation disorders
  • 197. If he has any of the following, use CAUTION Large varicocoel or hydrocoele (swollen veins or membranes in the spermatic cord or testes, causing swollen scrotum) Previous scrotal surgery or injury Undescended testicles – one side only (vasectomy is performed on the normal side only. Then if any sperm remains in the semen after 3 months, the other side must be done, too) Diabetes
  • 198. Having a vasectomy Counseling Requirement of safe procedure: Informed consent Infection prevention Client assessment Anaesthesia Instructions to client
  • 199.
    • Counseling to ensure Informed Choice &
    • Informed Consent are similar to Female Sterilisation
  • 200. GoI: Program, Guidelines and Standards in Sterilisation Services
  • 201. Evolution of Standards and Quality care in Family Planning
    • 1989 - First manual on standards for sterilisation
    • 1994 - ICPD (quality care in reproductive health)
    • 1996 - the first manual on quality assurance
    • 1997 - RCH I approach – special emphasis on
          • Client centered,
          • Need based,
          • High quality, Integrated services
          • Absence of targets
    • 2005 - RCH II/ NRHM
          • Upgraded facilities,
          • Improved trainings,
          • Gender sensitive approach,
          • Community participation
    • 2006 - Updated manuals on standards & QA
  • 202. Reasons for concern on quality
    • Standards and guidelines: Not followed
    • QACs: Non-functional
    • PIL against GOI and States - on quality in sterilisation services in public sector
    • Supreme court directives for stringently following standards laid down by GOI
  • 203. Observations of the Supreme Court
    • Lack of uniformity in sterilzation procedures
    • No norms followed for ensuring GOI guidelines
    • Poor documentation
    • Forms & formats (consent form) varying
    • Near absence of QACs
  • 204. Supreme court directives on sterilisations
    • GOI level
    • Eligibility criteria for service providers
    • Bring in an insurance scheme
    • Ensure uniform standards for sterilization in the country as laid down by the GOI
    • State level
    • States to constitute QACs at state and district levels
    • Empanelment of service providers as per laid down standards
    • Check list to be filled by providers before surgery
    • Consent to be taken before surgery
    • Maintenance of records and publishing reports quarterly
  • 205. What are Standards
    • Established by authority/custom
      • Measure for judging, comparing or serving
      • as an example
    • Professionally agreed levels
    • Broad descriptive statements
  • 206. Quality services focus on the clients rights to:
    • Information
    • Access to services
    • Informed choice
    • Safe services
    • Privacy & confidentiality
    • Dignity, comfort & expression of opinion
    • Continuity of care
  • 207. Purposes of Standards
    • Evaluate quality of care
    • Compare and Improve existing practices
    • Guidelines for practice & criteria for evaluation
    • Assist employers to know expectation of
    • employees
    • To improve documentation
  • 208. Purposes of Standards (contd)
    • Provide legal protection to healthcare practitioners.
    • To inform society of the concern of healthcare professionals for improvement of patient care practices
    • To assist public to understand the expectation from healthcare provider
  • 209. Quality assurance in Sterilisation Services
    • New initiatives:
      • Development of manuals on Standards in Male & Female Sterilisatiion & Quality Assurance in Sterilisation Services
      • Revised Compensation Scheme
      • Family Planning Insurance scheme
      • Accreditation of facilities & empanelment of doctors
      • Public-Private Partnerships (PPP) - Tool to measure assess, enable program managers and service providers to improve quality
      • Capacity Building of both public & private service providers in Laparoscopic Sterilisation & NSV Techniques
  • 210.  
  • 211. Broad guidelines in Quality Assurance Manual (1996)
    • Setting up Quality assurance committees at State and district levels
    • Tools developed for assessing quality of care
    • Tools for medical audits including death audits for mishaps following sterilisation
  • 212. Standards for Female & Male Sterilization
    • Contents
      • Eligibility of service providers for performing sterilization procedure
      • Providers Skill & Competency
      • Physical Requirements
      • Selection of Clients (elligibility criteria)
      • IP set up
  • 213. Eligibility of Providers for Performing Female Sterilization
    • MINILAP services
    • -- MBBS medical officers Trained & Certified in MINILAP
    • Laparoscopic Sterilisation
    • --DGO,
    • -- MD (OBGY)
    • -- MS (Surgery)
    Trained & Certified in Laparoscopic Sterilisation
  • 214. Eligibility of Providers for Performing Male Sterilization
    • Conventional Vasectomy Trained & Certified MBBS doctor
    • No Scalpel Vasectomy (NSV) Trained & Certified MBBS doctor
  • 215. Certificate of Sterilization
    • Female Sterilisation: Certificate of sterilization should be issued after one month of the surgery or, after the 1st menstrual period by the Medical Officer of the facility.
    • Male Sterilisation: ‘Certificate of surgery’ can be given after the procedure but ‘Certificate of Sterilisation’ should be given only after confirming Azoospermia in the semen, 3 months after the procedure.
  • 216. FAILURE OF OPERATION, LEADING TO PREGNANCY
    • ALL CASES OF FAILURE, COMPLICATIONS, MAJOR OR MINOR, ARISING DURING SURGERY OR POST-SURGERY MUST BE DOCUMENTED. THE COMPLICATIONS WHICH REQUIRED HOSPITALIZATION AND ALL CASES OF FAILURE MUST BE REPORTED TO THE DISTRICT QUALITY ASSURANCE COMMITTEE. THE QUALITY ASSURANCE COMMITTEE WILL IN TURN BE RESPONSIBLE FOR COMMUNICATING SUCH INFORMATION TO THE CONCERNED INSURANCE SERVICE PROVIDERS FOR COMPENSATION.
  • 217. National FPIS ( coverage to all Indian citizens who opt for sterilisation at any accredited facility)
    • SECTION – I (for clients)
    • Claims arising out of
            • deaths
            • failures
            • medical complications
    • ( The person shall mean any legally married person, male or female undergoing sterilization operation as per the protocol issued by Ministry of Health and Family Welfare)
    • SECTION – II (for providers)
    • Covers all accredited doctors and hospitals for sums which the insured or its doctor / health facility becomes legally liable to pay as damages to Third Party ( beneficiary)
  • 218. Policy features
    • Any claims arising out of sterilization operation after 29 th November 2005 would be admissible if detected during the policy period
    • The insurer will indemnify only if the claims are first made in writing against the insured or its doctor/facility during the period of insurance including legal costs and expenses incurred in prior consultation with the insured
  • 219. CLAIM PROCEDURE
    • Eligibility for Claim
    • Section1
    • It would be mandatory that before going through Sterilization Operation, the person concerned (applicant) must fill and submit ‘Application for sterilization operation and consent form’. This shall also facilitate nomination in case of unfortunate event of death
    • Section 2
    • All Govt. Institutions-central, state, local govt, public sectors, accredited private centres/doctors
    • The doctors should have been empanelled by the state as per qualification requirement
  • 220.
    • The DQAC/ CMO has the overall responsibility of implementing the FP insurance scheme in a district.
    • All settlements through the DQAC.
    • Responsible for regular monitoring of sterilisations – quality care, reporting and investigating failures, complications, deaths
  • 221. FAMILY PLANNING INSURANCE
    • Claims arising out of Sterilization Operation Amount
    • A Death at hospital/ within seven days of discharge Rs. 2,00,000/-
    • B Death due to sterilization (8 th – 30 th day from the
    • date of discharge ) Rs. 50,000/-
    • C Expenses for treatment of Medical Complications Rs. 25,000/-
    • (up to 60 days) and subject to maximum
    • D Failure of Sterilization Rs. 30,000/-
    • E Doctors/ Facilities covered for litigations up to
    • 4 cases per year including defence cost Rs. 2,00,000/-
    • Actions Taken by the division:
    • Dissemination meetings conducted for all state officials
    • Public institutions to display boards on the scheme
    _________________________
  • 222.
    • Following documents are to be submitted for claims under different eventualities .
    • Death due to sterilization.
      • Completed Claim cum QAC report in original
      • Attested copy of consent form
      • Post mortem report & FIR in medico legal cases.
      • Duly filled bank account opening form along with photographs of minors & guardian, age proof and residence proof.
    • Failure of Sterilization
      • Completed Claim cum QAC report in original.
      • Copy of the sterilisation certificate
      • Proof of failure in form of documents (like semen test report/ MTP/ delivery details)
      • Certificate from QAC/ CMO confirming failure of sterilization.
    • Claims due to Medical Complications (can be with or without death )
      • Completed Claim cum QAC report in original
      • Copy of the sterilisation certificate
      • Certificate from QAC/ CMO confirming the nature of Medical Complication with estimate of treatment expenses.
      • Bills, Cash memo, Test Reports etc.
    • Except the claim form, all the above documents would be photocopies & attested by the CMO
    • The death claim shall be settled in favour of the spouse and unmarried dependant children of the deceased or legal heirs.
  • 223. Following documents are to be submitted under section II
    • Copy of the summon/ FIR lodged against doctor &/or health facility
    • The CMO should certify that the sterilization was done by an accredited doctor &/ or health facility
    • Copy of the vakalatnama
  • 224. Claim Document
    • The claim under Section 1C & 1D shall be paid in the name of the beneficiary
    • The death claim shall be settled in favour of the spouse and unmarried dependent children in equal proportion. The name of the spouse and unmarried dependent children should be mentioned in the consent form filled by the person while enrolling herself/ himself for sterilisation operation
    • In case of no spouse, the payment shall be made to the unmarried dependent children. In case of minor dependent children, the payment shall be made through fixed deposit in a bank account by the insurer in the name of minor children to be payable on the date of their attaining majority. However, the interest accrued shall be paid to the children through their guardian on quarterly basis.
    • In case there are no surviving spouse/ unmarried dependent children, the claim shall then be payable to the legal heir of the deceased acceptor
  • 225. COMPENSATION For Public (Govt.) facilities High Focus States Breakage of the Compensation package Acceptor Motivator Drugs and dressing Surgeon charges Anesthetist Staff nurse OT technician/helper Refreshment Camp management Total VAS. (ALL) TUB. (ALL) 1100 600 200 150 50 100 100 75 - 25 15 15 15 15 10 10 10 10 1500 1000
  • 226. COMPENSATION B. For Private Facilities: High Focus States Type of operation Facility Motivator Total Vasectomy (ALL) Tubectomy (ALL) 1300 1350 200 150 1500 1500
  • 227. Need of the HOUR Involvement Partnership Commitment IMPROVING AVAILABILITY & QUALITY of CONTRACEPTIVE SERVICES PUBLIC & PRIVATE
  • 228. Orientation on safe abortion for private providers Dr. Dinesh Agarwal NPO(RH), UNFPA
  • 229. CAC guidelines consist of
    • Legal aspects of abortion care
    • Counseling
    • Clinical assessment
    • Infection prevention
    • Vacuum aspiration techniques for 1 st trimester abortions
    • Medical methods of abortion
    • Termination of 2 nd trimester pregnancies
  • 230. Legal Aspects of Abortion Care
  • 231.  
  • 232.  
  • 233.  
  • 234. Facilities required for site appro val MTP rules segregate sites which offer only 1 st trimester MTPs & sites that offer MTPs up to 20 weeks. For MTP up to 12 weeks For MTP up to 20 weeks Gynecological examination/ labor table Operation table Resuscitation & sterilization equipment Instrument for performing abdominal or gynecological surgery Drugs & parenteral fluid Anesthetic equipment Back up facilities for treatment of shock & facilities for transportation Resuscitation & sterilization equipment Drugs & parenteral fluids for emergency use notified by the government of India from time to time
  • 235.  
  • 236.  
  • 237. Counselling
  • 238.  
  • 239.  
  • 240.  
  • 241. Clinical Assessment
  • 242.  
  • 243.  
  • 244.  
  • 245. Infection Prevention
  • 246.  
  • 247.  
  • 248.  
  • 249.  
  • 250. Vacuum Aspiration Techniques for 1 st trimester MTP
  • 251.  
  • 252.  
  • 253.  
  • 254.  
  • 255. Manual Vacuum Aspiration
  • 256.  
  • 257.  
  • 258.  
  • 259.  
  • 260.  
  • 261. Medical Methods of Abortion (MMA)
  • 262. Introduction
    • Non-surgical methods of abortion using a combination of drugs
    • New and safe option for MTP
    • Potential to increase access to safe abortion services
    Drugs used
    • Combination of mifepristone and misoprostol
    • WHO recommends use of this combination for up to 63 days (9 weeks) of pregnancy
    • GoI guidelines recommend its use for early abortions up to 49 days
    • (7 weeks)
    • Recently the DCGI has approved a combipack of the two drugs (1 tab of mifepristone 200mg+ 4 tab of misoprostol 200mcg) for use up to 63 days (9 weeks) of pregnancy
  • 263. Efficacy of MMA
    • Few cases of failure:
    • 1% women may require surgical evacuation for heavy bleeding
    • 1% may fail to abort
    • 2-3% may be incomplete abortion, necessitating surgical evacuation
    • 1-2 per 1000 women may have excessive bleeding requiring blood transfusion
    Success rate of 95-98%
  • 264. Eligibility Criteria
    • Provider and place
    • Registered medical practitioner as per the MTP Act
    • Approved MTP site
    • or
    • Non-approved site with certificate of referral links from owner of an
    • approved site, displayed in the clinic
    • Eligibility of the woman
    • Is willing to come for 3 visits
    • Has access to appropriate health facility during emergency
    • Agrees for surgical procedure if methods fails
    • No medical contraindications
  • 265. MMA protocol
    • Prepare the woman for MMA
    • Provide counselling and obtain written consent
    • Assess eligibility of woman
    • Investigations
    • - Essential: Hb%, urine, ABO Rh
    • - Optional: USG if disparity in period of gestation &
    • uterine size, suspected ectopic, fibroid
  • 266. MMA drug protocol Protocols for mifepristone & misoprostol administration Gestational Age Mifepristone on Day 1 Misoprostol on Day 3 Dose Route Recommended options Up to 49 days 200 mg orally (one 200 mg tablet) 400 μ g (two 200 μ g tablets) Oral/ vaginal Up to 63 days 200 mg orally (one 200 mg tablet) 800 μ g (four 200 μ g tablets) Sublingual/ vaginal
  • 267. Side effects & complications
    • Side effects
    • Bleeding & cramping
    • Severe vaginal bleeding
    • Fever, warmth & chills
    • Cramping
    • Gastrointestinal side effects – nausea, vomiting, and diarrhea
    • Headache and dizziness
    • Complications
    • Failed abortion
    • Haemorrhage
    • Infection
  • 268.  
  • 269. Methods of 2 nd Trimester Abortion
  • 270.  
  • 271.  
  • 272. Methods S econd trimester pregnancy termination Induction method: Emcredyl Instillation Surgical Method: Dilatation & Evacuation (D&E) Medical method: Combination of mifepristone & misoprostol *This is currently not an approved method for 2 nd trimester MTP in India
  • 273.  
  • 274.